Diagnostic terminology for urinary cytology reports including the new subcategories 'atypical urothelial cells of undetermined significance' (AUC-US) and 'cannot exclude high grade' (AUC-H)
Objective We studied whether atypical, non‐superficial urothelial cells (AUC) could be separated into new subcategories including AUC ‘of undetermined significance’ (AUC‐US) and ‘cannot exclude high grade’’ (AUC‐H) in order to help to standardize urine cytopathology reports, as it is widely accepted...
Gespeichert in:
Veröffentlicht in: | Cytopathology (Oxford) 2014-02, Vol.25 (1), p.27-38 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 38 |
---|---|
container_issue | 1 |
container_start_page | 27 |
container_title | Cytopathology (Oxford) |
container_volume | 25 |
creator | Piaton, E. Decaussin-Petrucci, M. Mege-Lechevallier, F. Advenier, A.-S. Devonec, M. Ruffion, A. |
description | Objective
We studied whether atypical, non‐superficial urothelial cells (AUC) could be separated into new subcategories including AUC ‘of undetermined significance’ (AUC‐US) and ‘cannot exclude high grade’’ (AUC‐H) in order to help to standardize urine cytopathology reports, as it is widely accepted in the Bethesda system for gynaecological cytopathology.
Methods
We investigated whether AUC‐US and AUC‐H, defined by distinctive cytological criteria, might be separated with statistical significance according to actual diagnosis and follow‐up data. A series of 534 cyto‐histological comparisons taken in 139 patients, including 221 AUC at various steps of their clinical history was studied. There were 513 (96.1%) postcystoscopy and 469 (87.8%) ThinPrep® liquid‐based specimens (95.9% and 89.1% of AUC cases, respectively). Patients viewed between 1999 and 2011 had histological control in a 0‐ to 6‐months delay and were followed‐up during an additional 5.9 ± 9.2 (0‐ to 56‐) months period.
Results
The 221 AUC represented 0.8–2% of the specimens viewed during the study period. Among AUC‐H cases, 70 out of 185 (37.8%) matched with high‐grade lesions, compared with 3 of 38 (8.3%) of AUC‐US cases (P = 0.0003). Conservatively treated patients with AUC‐H more frequently developed high‐grade lesions than those with AUC‐US (54.1% versus 16.7%, P = 0.0007) with a 17.6‐months mean delay. Nuclear hyperchromasia, a nuclear to cytoplasm (N/C) ratio > 0.7 and the combination of both were the more informative diagnostic criteria, all with P |
doi_str_mv | 10.1111/cyt.12050 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1490752310</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1490752310</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3630-9f7d3eab262659966f2a3a3972ffb5bcf78cb792dc24e847a17e2c7e0e3142703</originalsourceid><addsrcrecordid>eNp1kc9y0zAQhzUMDA2FAy_A6Jbm4FZ_bCs-dgI0DAEONAOcNLK8cgSOFCR7Wj8c74aCm97QRZqdb78d7Q-h15Rc0nSu9NhfUkYK8gTNKC-LjHHCn6IZqYoyKwoiztCLGH8SQlnF-HN0xnheUkGrGfrz1qrW-dhbjXsIe-t859sRGx_wEKxTYcRJPxUDHHzoI7ZOd0NjXYv7HWAHdzgOtVY9tD5YiHiu-vFgteqSwieks-mpoesi9gYProFpFDQ42tZZk1inYY4vrrerbPt1gZVr8DwVne8x3B-nAd7ZdofboJoTuF68RM-M6iK8erjP0fb9u9vVOtt8ufmwut5kmpecZJURDQdVs5KVRVWVpWGKK14JZkxd1NqIpa5FxRrNcljmQlEBTAsgwGnOBOHn6GLyHoL_PUDs5d7G44eUAz9ESfOKiIJxekQXE6qDjzGAkYdg92mNkhJ5TEumdcp_aSX2zYN2qPfQPJKneBJwNQF3toPx_ya5-nF7UmZTh4093D92qPBLloKLQn77fCOX60_fN_mykh_5X-xzsFc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1490752310</pqid></control><display><type>article</type><title>Diagnostic terminology for urinary cytology reports including the new subcategories 'atypical urothelial cells of undetermined significance' (AUC-US) and 'cannot exclude high grade' (AUC-H)</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Piaton, E. ; Decaussin-Petrucci, M. ; Mege-Lechevallier, F. ; Advenier, A.-S. ; Devonec, M. ; Ruffion, A.</creator><creatorcontrib>Piaton, E. ; Decaussin-Petrucci, M. ; Mege-Lechevallier, F. ; Advenier, A.-S. ; Devonec, M. ; Ruffion, A.</creatorcontrib><description>Objective
We studied whether atypical, non‐superficial urothelial cells (AUC) could be separated into new subcategories including AUC ‘of undetermined significance’ (AUC‐US) and ‘cannot exclude high grade’’ (AUC‐H) in order to help to standardize urine cytopathology reports, as it is widely accepted in the Bethesda system for gynaecological cytopathology.
Methods
We investigated whether AUC‐US and AUC‐H, defined by distinctive cytological criteria, might be separated with statistical significance according to actual diagnosis and follow‐up data. A series of 534 cyto‐histological comparisons taken in 139 patients, including 221 AUC at various steps of their clinical history was studied. There were 513 (96.1%) postcystoscopy and 469 (87.8%) ThinPrep® liquid‐based specimens (95.9% and 89.1% of AUC cases, respectively). Patients viewed between 1999 and 2011 had histological control in a 0‐ to 6‐months delay and were followed‐up during an additional 5.9 ± 9.2 (0‐ to 56‐) months period.
Results
The 221 AUC represented 0.8–2% of the specimens viewed during the study period. Among AUC‐H cases, 70 out of 185 (37.8%) matched with high‐grade lesions, compared with 3 of 38 (8.3%) of AUC‐US cases (P = 0.0003). Conservatively treated patients with AUC‐H more frequently developed high‐grade lesions than those with AUC‐US (54.1% versus 16.7%, P = 0.0007) with a 17.6‐months mean delay. Nuclear hyperchromasia, a nuclear to cytoplasm (N/C) ratio > 0.7 and the combination of both were the more informative diagnostic criteria, all with P < 0.01.
Conclusion
We conclude that the new subcategories could help to standardize urine cytopathology reports and contribute to the patient's management, provided it is validated by multicentric studies.</description><identifier>ISSN: 0956-5507</identifier><identifier>EISSN: 1365-2303</identifier><identifier>DOI: 10.1111/cyt.12050</identifier><identifier>PMID: 23461719</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Aged ; Aged, 80 and over ; atypical urothelial cells ; bladder cancer ; Cytodiagnosis ; Epithelial Cells - pathology ; Female ; high grade ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; reporting ; terminology ; Terminology as Topic ; Urinary Bladder Neoplasms - diagnosis ; Urinary Bladder Neoplasms - pathology ; urinary cytology ; Uterine Cervical Neoplasms - diagnosis ; Uterine Cervical Neoplasms - pathology</subject><ispartof>Cytopathology (Oxford), 2014-02, Vol.25 (1), p.27-38</ispartof><rights>2013 John Wiley & Sons Ltd</rights><rights>2013 John Wiley & Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3630-9f7d3eab262659966f2a3a3972ffb5bcf78cb792dc24e847a17e2c7e0e3142703</citedby><cites>FETCH-LOGICAL-c3630-9f7d3eab262659966f2a3a3972ffb5bcf78cb792dc24e847a17e2c7e0e3142703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fcyt.12050$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fcyt.12050$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27931,27932,45581,45582</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23461719$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Piaton, E.</creatorcontrib><creatorcontrib>Decaussin-Petrucci, M.</creatorcontrib><creatorcontrib>Mege-Lechevallier, F.</creatorcontrib><creatorcontrib>Advenier, A.-S.</creatorcontrib><creatorcontrib>Devonec, M.</creatorcontrib><creatorcontrib>Ruffion, A.</creatorcontrib><title>Diagnostic terminology for urinary cytology reports including the new subcategories 'atypical urothelial cells of undetermined significance' (AUC-US) and 'cannot exclude high grade' (AUC-H)</title><title>Cytopathology (Oxford)</title><addtitle>Cytopathology</addtitle><description>Objective
We studied whether atypical, non‐superficial urothelial cells (AUC) could be separated into new subcategories including AUC ‘of undetermined significance’ (AUC‐US) and ‘cannot exclude high grade’’ (AUC‐H) in order to help to standardize urine cytopathology reports, as it is widely accepted in the Bethesda system for gynaecological cytopathology.
Methods
We investigated whether AUC‐US and AUC‐H, defined by distinctive cytological criteria, might be separated with statistical significance according to actual diagnosis and follow‐up data. A series of 534 cyto‐histological comparisons taken in 139 patients, including 221 AUC at various steps of their clinical history was studied. There were 513 (96.1%) postcystoscopy and 469 (87.8%) ThinPrep® liquid‐based specimens (95.9% and 89.1% of AUC cases, respectively). Patients viewed between 1999 and 2011 had histological control in a 0‐ to 6‐months delay and were followed‐up during an additional 5.9 ± 9.2 (0‐ to 56‐) months period.
Results
The 221 AUC represented 0.8–2% of the specimens viewed during the study period. Among AUC‐H cases, 70 out of 185 (37.8%) matched with high‐grade lesions, compared with 3 of 38 (8.3%) of AUC‐US cases (P = 0.0003). Conservatively treated patients with AUC‐H more frequently developed high‐grade lesions than those with AUC‐US (54.1% versus 16.7%, P = 0.0007) with a 17.6‐months mean delay. Nuclear hyperchromasia, a nuclear to cytoplasm (N/C) ratio > 0.7 and the combination of both were the more informative diagnostic criteria, all with P < 0.01.
Conclusion
We conclude that the new subcategories could help to standardize urine cytopathology reports and contribute to the patient's management, provided it is validated by multicentric studies.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>atypical urothelial cells</subject><subject>bladder cancer</subject><subject>Cytodiagnosis</subject><subject>Epithelial Cells - pathology</subject><subject>Female</subject><subject>high grade</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Grading</subject><subject>reporting</subject><subject>terminology</subject><subject>Terminology as Topic</subject><subject>Urinary Bladder Neoplasms - diagnosis</subject><subject>Urinary Bladder Neoplasms - pathology</subject><subject>urinary cytology</subject><subject>Uterine Cervical Neoplasms - diagnosis</subject><subject>Uterine Cervical Neoplasms - pathology</subject><issn>0956-5507</issn><issn>1365-2303</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc9y0zAQhzUMDA2FAy_A6Jbm4FZ_bCs-dgI0DAEONAOcNLK8cgSOFCR7Wj8c74aCm97QRZqdb78d7Q-h15Rc0nSu9NhfUkYK8gTNKC-LjHHCn6IZqYoyKwoiztCLGH8SQlnF-HN0xnheUkGrGfrz1qrW-dhbjXsIe-t859sRGx_wEKxTYcRJPxUDHHzoI7ZOd0NjXYv7HWAHdzgOtVY9tD5YiHiu-vFgteqSwieks-mpoesi9gYProFpFDQ42tZZk1inYY4vrrerbPt1gZVr8DwVne8x3B-nAd7ZdofboJoTuF68RM-M6iK8erjP0fb9u9vVOtt8ufmwut5kmpecZJURDQdVs5KVRVWVpWGKK14JZkxd1NqIpa5FxRrNcljmQlEBTAsgwGnOBOHn6GLyHoL_PUDs5d7G44eUAz9ESfOKiIJxekQXE6qDjzGAkYdg92mNkhJ5TEumdcp_aSX2zYN2qPfQPJKneBJwNQF3toPx_ya5-nF7UmZTh4093D92qPBLloKLQn77fCOX60_fN_mykh_5X-xzsFc</recordid><startdate>201402</startdate><enddate>201402</enddate><creator>Piaton, E.</creator><creator>Decaussin-Petrucci, M.</creator><creator>Mege-Lechevallier, F.</creator><creator>Advenier, A.-S.</creator><creator>Devonec, M.</creator><creator>Ruffion, A.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201402</creationdate><title>Diagnostic terminology for urinary cytology reports including the new subcategories 'atypical urothelial cells of undetermined significance' (AUC-US) and 'cannot exclude high grade' (AUC-H)</title><author>Piaton, E. ; Decaussin-Petrucci, M. ; Mege-Lechevallier, F. ; Advenier, A.-S. ; Devonec, M. ; Ruffion, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3630-9f7d3eab262659966f2a3a3972ffb5bcf78cb792dc24e847a17e2c7e0e3142703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>atypical urothelial cells</topic><topic>bladder cancer</topic><topic>Cytodiagnosis</topic><topic>Epithelial Cells - pathology</topic><topic>Female</topic><topic>high grade</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Grading</topic><topic>reporting</topic><topic>terminology</topic><topic>Terminology as Topic</topic><topic>Urinary Bladder Neoplasms - diagnosis</topic><topic>Urinary Bladder Neoplasms - pathology</topic><topic>urinary cytology</topic><topic>Uterine Cervical Neoplasms - diagnosis</topic><topic>Uterine Cervical Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Piaton, E.</creatorcontrib><creatorcontrib>Decaussin-Petrucci, M.</creatorcontrib><creatorcontrib>Mege-Lechevallier, F.</creatorcontrib><creatorcontrib>Advenier, A.-S.</creatorcontrib><creatorcontrib>Devonec, M.</creatorcontrib><creatorcontrib>Ruffion, A.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cytopathology (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Piaton, E.</au><au>Decaussin-Petrucci, M.</au><au>Mege-Lechevallier, F.</au><au>Advenier, A.-S.</au><au>Devonec, M.</au><au>Ruffion, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnostic terminology for urinary cytology reports including the new subcategories 'atypical urothelial cells of undetermined significance' (AUC-US) and 'cannot exclude high grade' (AUC-H)</atitle><jtitle>Cytopathology (Oxford)</jtitle><addtitle>Cytopathology</addtitle><date>2014-02</date><risdate>2014</risdate><volume>25</volume><issue>1</issue><spage>27</spage><epage>38</epage><pages>27-38</pages><issn>0956-5507</issn><eissn>1365-2303</eissn><abstract>Objective
We studied whether atypical, non‐superficial urothelial cells (AUC) could be separated into new subcategories including AUC ‘of undetermined significance’ (AUC‐US) and ‘cannot exclude high grade’’ (AUC‐H) in order to help to standardize urine cytopathology reports, as it is widely accepted in the Bethesda system for gynaecological cytopathology.
Methods
We investigated whether AUC‐US and AUC‐H, defined by distinctive cytological criteria, might be separated with statistical significance according to actual diagnosis and follow‐up data. A series of 534 cyto‐histological comparisons taken in 139 patients, including 221 AUC at various steps of their clinical history was studied. There were 513 (96.1%) postcystoscopy and 469 (87.8%) ThinPrep® liquid‐based specimens (95.9% and 89.1% of AUC cases, respectively). Patients viewed between 1999 and 2011 had histological control in a 0‐ to 6‐months delay and were followed‐up during an additional 5.9 ± 9.2 (0‐ to 56‐) months period.
Results
The 221 AUC represented 0.8–2% of the specimens viewed during the study period. Among AUC‐H cases, 70 out of 185 (37.8%) matched with high‐grade lesions, compared with 3 of 38 (8.3%) of AUC‐US cases (P = 0.0003). Conservatively treated patients with AUC‐H more frequently developed high‐grade lesions than those with AUC‐US (54.1% versus 16.7%, P = 0.0007) with a 17.6‐months mean delay. Nuclear hyperchromasia, a nuclear to cytoplasm (N/C) ratio > 0.7 and the combination of both were the more informative diagnostic criteria, all with P < 0.01.
Conclusion
We conclude that the new subcategories could help to standardize urine cytopathology reports and contribute to the patient's management, provided it is validated by multicentric studies.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>23461719</pmid><doi>10.1111/cyt.12050</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0956-5507 |
ispartof | Cytopathology (Oxford), 2014-02, Vol.25 (1), p.27-38 |
issn | 0956-5507 1365-2303 |
language | eng |
recordid | cdi_proquest_miscellaneous_1490752310 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | Aged Aged, 80 and over atypical urothelial cells bladder cancer Cytodiagnosis Epithelial Cells - pathology Female high grade Humans Male Middle Aged Neoplasm Grading reporting terminology Terminology as Topic Urinary Bladder Neoplasms - diagnosis Urinary Bladder Neoplasms - pathology urinary cytology Uterine Cervical Neoplasms - diagnosis Uterine Cervical Neoplasms - pathology |
title | Diagnostic terminology for urinary cytology reports including the new subcategories 'atypical urothelial cells of undetermined significance' (AUC-US) and 'cannot exclude high grade' (AUC-H) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T02%3A33%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnostic%20terminology%20for%20urinary%20cytology%20reports%20including%20the%20new%20subcategories%20'atypical%20urothelial%20cells%20of%20undetermined%20significance'%20(AUC-US)%20and%20'cannot%20exclude%20high%20grade'%20(AUC-H)&rft.jtitle=Cytopathology%20(Oxford)&rft.au=Piaton,%20E.&rft.date=2014-02&rft.volume=25&rft.issue=1&rft.spage=27&rft.epage=38&rft.pages=27-38&rft.issn=0956-5507&rft.eissn=1365-2303&rft_id=info:doi/10.1111/cyt.12050&rft_dat=%3Cproquest_cross%3E1490752310%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1490752310&rft_id=info:pmid/23461719&rfr_iscdi=true |